ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN)
CUSIP: 74346M406
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 9,081,600
- Total 13F shares
- 3,232,221
- Share change
- -120,320
- Total reported value
- $4,848,022
- Price per share
- $1.50
- Number of holders
- 15
- Value change
- -$221,623
- Number of buys
- 2
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74346M406:
Top shareholders of PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
20%
|
1,834,047
|
$3,503,030 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
12%
|
1,059,582
|
$2,023,802 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.9%
|
265,958
|
$507,980 | — | 31 Mar 2024 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Northeast Financial Consultants Inc |
13F
|
Company |
1.1%
|
100,000
|
$191,000 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.33%
|
30,366
|
$59,821 | — | 31 Mar 2024 | |
| Hara Capital LLC |
13F
|
Company |
0.32%
|
29,416
|
$56,185 | — | 31 Mar 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.29%
|
26,042
|
$49,740 | — | 31 Mar 2024 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.22%
|
20,008
|
$38,215 | — | 31 Mar 2024 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
10,830
|
$21,000 | — | 31 Mar 2024 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| Sandy Spring Bank |
13F
|
Company |
0.04%
|
3,300
|
$6,303 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$3,182 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
713
|
$1,000 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
333
|
$599 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
253
|
$484 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
250
|
$478 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
143
|
$273 | — | 31 Mar 2024 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) as of Q2 2024
As of 30 Jun 2024,
ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,232,221 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Affinity Asset Advisors, LLC, Hara Capital LLC, IEQ CAPITAL, LLC, Fiduciary Trust Co, Claret Asset Management Corp, Sandy Spring Bank, BANK OF AMERICA CORP /DE/, and Royal Bank of Canada.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
16
Q2 2024 holders
15
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.